(603122)"COWEALTH MEDICAL CHINA CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 603122 · · 13 pages · Chinese
Summary by 6ix AI
The report indicates that the company has experienced a decline in both revenue and net profit compared to the previous year. It also highlights the company's commitment to ensuring the accuracy and completeness of the financial information presented. The financial statements included in the report have not been audited, which is noted in the document.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Cowealth Medical China Co., Ltd. on 6ix
Earlier from Cowealth Medical China
- (603122)"COWEALTH MEDICAL CHINA CO., LTD."Brief Report on Cumulative Operating Revenue for January–September 2026
- Brief Report on Cumulative Operating Revenue for January–August 2026
- Announcement on Attending the 2026 Collective Reception Day for Listed Companies in Shanghai Jurisdiction and Interim Performance Briefing
- Announcement on Outline of the 2026 Semi-annual Performance Briefing
- Announcement on Provision for Asset Impairment Losses for the First Half of 2026
Later from Cowealth Medical China
All Cowealth Medical China news releasesFollow Cowealth Medical China into a list and get an email when it puts out news.
Follow Cowealth Medical China